Inventor · disambiguated record
Thomas Duhen
Also filed as: DUHEN THOMAS
2 granted patents·2 pending applications·2 citations·filing 2001–2022
41Inventor score
Top patents by PatentIndex Score
4 records- 0176US11572541B2Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancerPROVIDENCE HEALTH & SERVICES—OREGON·Filed 2018·Granted Feb 7, 2023·2 cites·10 claims
- 0269US12358968B2Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancerPROVIDENCE HEALTH & SERVICES—OREGON·Filed 2022·Granted Jul 15, 2025·0 cites·18 claims
- 0349US2024277842A1Cxcr5, pd-1, and icos expressing tumor reactive cd4 t cells and their useWEINBERG ANDREW D·Filed 2022·Application pending·0 cites
- 0439US2005118575A1Dendritic cell-derived nucleic acids and related compositions and methodsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Duhen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →